About:

The H.C. Wainwright 4th Annual Cell Therapy Conference is a focused virtual gathering at the intersection of capital and one of biotech's most actively invested modalities. Held June 30 – July 1, 2026, the program brings together public and private cell therapy companies, institutional investors, private equity, venture capital, and industry executives.

Programming includes company presentations from cell therapy developers, 1-on-1 investor meetings, and dedicated networking with H.C. Wainwright's investment banking and research teams. As cell and gene therapy continues to generate some of the largest clinical and commercial questions in life sciences, the conference functions as a strategic checkpoint for capital allocators and operators tracking the category.

For leaders in cell therapy, advanced therapeutics, and biotech investing, this conference offers a concentrated virtual format that's particularly accessible for those who can't travel during the start of summer.

🔗 Visit the official event site →

Take your seat at the table. Apply to The Uplyft Collective →